发明公开
- 专利标题： DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE
- 专利标题（中）： 二氢-3,5-二酮衍生金融工具
-
申请号： EP14765619申请日： 2014-03-13
-
公开(公告)号： EP2975030A4公开(公告)日： 2016-08-03
- 发明人: OHTAKE YOSHIHITO , OKAMOTO NAOKI , ONO YOSHIYUKI , KASHIWAGI HIROTAKA , KIMBARA ATSUSHI , HARADA TAKEO , HORI NOBUYUKI , MURATA YOSHIHISA , TACHIBANA KAZUTAKA , TANAKA SHOTA , NOMURA KENICHI , IDE MITSUAKI , MIZUGUCHI EISAKU , ICHIDA YASUHIRO , OHTOMO SHUICHI , HORIBA NAOSHI
- 申请人： CHUGAI PHARMACEUTICAL CO LTD
- 专利权人： CHUGAI PHARMACEUTICAL CO LTD
- 当前专利权人： CHUGAI PHARMACEUTICAL CO LTD
- 优先权： JP2013051082 2013-03-13; JP2013132889 2013-06-25
- 主分类号： C07D237/04
- IPC分类号： C07D237/04 ; A61K31/50 ; A61K31/501 ; A61K31/5025 ; A61K31/504 ; A61K31/506 ; A61K31/5377 ; A61P3/12 ; A61P13/12 ; A61P43/00 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D471/04 ; C07D487/04 ; C07D487/18
摘要：
The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure, comprising the compound as an active ingredient, and a method for prevention and/or treatment.
信息查询
